Modular Medical Inc

For the period ended Mar 31, 2025. Filed Jun 20, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Jun 20, 2025

MODD$1.85+39.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 15. EXHIBITS

(a) Consolidated Financial Statements

The following documents are filed as part of this Report:

●	Consolidated Financial Statements and Report of Independent Registered Public Accounting Firm, all of which are set forth are set forth under Part II, Item 8 of this Report.

(b) Financial Statement Schedules

Financial statement schedules may omitted because they are not applicable, not required, or because the required information is included in the consolidated financial statements or notes thereto.

(c) Exhibits:

Required exhibits are incorporated by reference or are filed with this Report.

Exhibit · Reference · Filed or Furnished
Number	Exhibit Description	Form	Exhibit	Filing Date	Herewith
1.3**	Sales Agreement, dated as of November 22, 2023, between Modular Medical, Inc. and Leerink Partners LLC	8-K	1.1	11/22/2023
2.1**	Reorganization and Share Exchange Agreement dated as of July 24, 2017, by and among Modular Medical, Inc., Quasuras, Inc., Paul DiPerna and the other stockholders of Quasuras, Inc.	8-K	2.1	07/28/2017
2.2	Addendum No. 1 to Reorganization and Share Exchange Agreement dated as of July 24, 2017, by and among Modular Medical, Inc., Quasuras, Inc., Paul DiPerna and the other Stockholders of Quasuras, Inc. dated May 3, 2021	8-K	2.2	05/12/2021
3.1	Third Amended and Restated Articles of Incorporation, as filed with the Secretary of State of Nevada on June 27, 2017	8-K	3.1	06/29/2017
3.2	Certificate of Amendment to the Amended and Restated Articles of Incorporation of Modular Medical, Inc., filed with the Secretary of State of the State of Nevada on November 24, 2021	8-K	3.1	12/01/2021
3.3	Certificate of Amendment to the Amended and Restated Articles of Incorporation of Modular Medical, Inc., filed with the Secretary of State of the State of Nevada on February 15, 2024	8-K	3.1	02/15/2024
3.4	Amended Bylaws	10-SB	3.2	03/08/2002
4.1*	Amended and Restated 2017 Equity Incentive Plan, as amended				X
4.2	Form of Warrant to Purchase Common Stock dated February 14, 2022	8-K	4.1	02/14/2022
4.3	Form of Pre-Funded Warrant to Purchase Common Stock dated May 2, 2022	8-K	4.1	05/05/2022
4.4	Form of Private Placement Warrant dated May 2, 2022	8-K	4.2	05/05/2022
4.5	Form of Investor Warrant dated May 2, 2022	S-1/A	4.5	05/05/2023
4.6	Form of Underwriter’s Warrant dated May 2, 2022	S-1/A	4.6	05/05/2023
4.7	Description of Registrant’s Securities	10-K	4.7	06/26/2023
4.8**	Underwriting Agreement, dated as of November 21, 2024, between Modular Medical, Inc. and Titan Partners Group LLC	8-K	1.1	11/25/2024
4.9	Form of Underwriter Warrant dated November 25, 2024	8-K	4.1	11/25/2024
4.10	Form of Investor Common Stock Purchase Warrant dated March 26, 2025	8-K	4.1	03/26/2025
4.11	Form of Placement Agent Warrant dated March 26, 2025	8-K	4.2	03/26/2025
10.1*	Employment Agreement dated August 1, 2018, by and between Modular Medical, Inc. and Paul DiPerna	S-1	10.4	06/27/2019
10.2	Intellectual Property Assignment Agreement dated July 24, 2017, by and between Modular Medical, Inc., Quasuras, Inc. and Paul DiPerna	8-K	10.3	07/28/2017
10.3*	Technology Royalty Agreement dated as of July 24, 2017, by and between Modular Medical, Inc., Quasuras, Inc. and Paul DiPerna	8-K	10.4	07/28/2017
10.4	Standard Industrial/Commercial Agreement between Modular Medical, Inc. and Michael Summers dated January 5, 2023	S-1	10.28	04/24/2023
10.5*	Form of Indemnification Agreement between Modular Medical, Inc. and each of its directors and officers used from January 23, 2020	10-Q	10.15	02/13/2020
10.6*	Form of Notice of Stock Option Grant and Stock Option Agreement under the Amended 2017 Equity Incentive Plan	10-Q	10.16	02/13/2020
10.7*	First Amendment to the Employment Agreement between Modular Medical, Inc. and Paul DiPerna effective as of May 12, 2020	8-K	10.18	05/27/2020
10.8*	Second Amendment to Employment Agreement between Modular Medical, Inc. and Paul DiPerna effective as of July 1, 2020	10-Q	10.20	08/12/2020

10.9	Form of Convertible Promissory Note issued in the 2021 Private Placement	8-K	10.21	05/12/2021
10.10**	Form of Common Stock Purchase Agreement dated March 2020 by and between Modular Medical, Inc. and the Investors named therein	S-1	10.17	04/09/2020
10.11**	Form of Securities Purchase Agreement for the 2021 Private Placement	8-K	10.23	05/12/2021
10.12**	Form of Registration Rights Agreement for the 2021 Private Placement	8-K	10.24	05/12/2021
10.13	Form of Common Stock Purchase Warrant issued in the 2021 Private Placement	8-K	10.22	05/12/2021
10.14	Warrant Agency Agreement between Modular Medical, Inc. and Colonial Stock Transfer Company, Inc., dated February 14, 2022	8-K	10.1	02/14/2022
10.15	Form of Warrant Omnibus Amendment Agreement	S-1/A	10.31	02/07/2022
10.16**	Form of Securities Purchase Agreement dated May 2, 2022	8-K	10.1	05/05/2022
10.17*	Severance and Release Agreement between Modular Medical, Inc. and Ellen O’Connor Vos dated February 23, 2022	S-1	10.33	07/06/2022
10.18*	Offer Letter Agreement between Modular Medical, Inc. and Kevin Schmid dated July 13, 2022	8-K	10.1	07/26/2022
10.19*	Form of Notice of Grant of Restricted Stock Unit Award and Agreement under the Amended and Restated Modular Medical, Inc. 2017 Equity Incentive Plan	10-Q	4.11	08/14/2023
10.20	Form of Warrant Agency Agreement	S-1/A	10.29	05/05/2023
10.21**	Form of Common Stock Purchase Agreement dated October 28, 2021 between Modular Medical, Inc. and the Investors named therein	8-K	10.29	10/29/2021
10.22*	Modular Medical, Inc. Two-Part FDA Submission and Clearance Milestone Bonus Program	8-K	10.1	10/05/2023
10.23*	Third Amendment to Employment Agreement between the Company and Paul DiPerna	8-K	10.1	04/10/2024
10.24**	Form of Securities Purchase Agreement dated March 26, 2025	8-K	10.1	03/26/2025
10.25**	Form of Subscription Agreement dated March 25, 2025	8-K	10.2	03/26/2025
14.1	Code of Business Conduct and Ethics				X
19.1	Insider Trading Compliance Program				X
21.1	Sole Subsidiary of Modular Medical, Inc. (as disclosed in the Notes to Consolidated Financial Statements as of March 31, 2025 in Item 8 of this Report)				X
23.1	Consent of Independent Registered Public Accounting Firm				X
24.1	Power of Attorney (see signature page of this Report)				X
31.1	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002				X
31.2	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002				X
32.1	Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002				X
97.1	Compensation Recovery Policy	10-K	97.1	06/21/2024
101.INS	Inline XBRL Instance Document.				X
101.SCH	Inline XBRL Taxonomy Extension Schema Linkbase Document.				X
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document.				X
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.				X
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document.				X
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document.				X
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).				X

*	Indicates a management contract or compensatory plan or arrangement.

**	Certain schedules, exhibits and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. Modular Medical, Inc. hereby undertakes to furnish copies of such omitted materials supplementally upon request by the SEC.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.